A Partnership to Translate an Evidence-based Intervention (Take Heart) for Vulnerable Older Adults With Heart Disease



Status:Active, not recruiting
Conditions:Peripheral Vascular Disease, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:50 - Any
Updated:1/23/2019
Start Date:December 2016
End Date:March 2021

Use our guide to learn which trials are right for you!

A Partnership to Translate an Evidence-based Intervention for Vulnerable Older Adults With Heart Disease

To evaluate the effectiveness of Take Heart, a behavioral/educational program for adults age
50+ with heart disease, or with at least two risk factors for heart disease, that helps them
to better manage their health condition(s). Take Heart is a new version of an evidence-based
program that has recently been adapted to be suitable for the needs of adults residing in
Detroit.

In this study, a heart disease self-management program will be tested in a low-income,
predominantly African-American community via a partnership with the Detroit Area Agency on
Aging (DAAA), the Detroit Medical Center (DMC), and University of Michigan School of Public
Health's Center for Managing Chronic Disease (CMCD). The specific aims of the research are
to: (1) adapt existing program materials to be appropriate for the new target population,
getting feedback from various sources including focus group interviews; (2) conduct a pilot
study of the adapted "Take Heart" program; (3) refine the intervention and conduct a
randomized trial with 376 participants age 50 years and over, to assess health outcomes; (4)
assess the translation and implementation of the intervention in the target setting and
identify factors that help and hinder the process; (5) assess cost savings associated with
the intervention; and (6) develop guidelines for "scaling up", that is, for replicating the
program in other low-income areas through the national network of Area Agencies on Aging.

Inclusion criteria:

50 years or older

1 or more diagnosed cardiovascular conditions, including:

- Atrial fibrillation

- Angina

- Myocardial infarction

- Congestive heart failure

- Valvular disease (aortic stenosis or mitral regurgitation)

- Peripheral vascular disease

- Pulmonary hypertension

- OR >2 major risk factors for cardiovascular disease (CVD; high cholesterol, high blood
pressure, smoking, diabetes, chronic kidney disease-stage 3 or 4)

- Must have access to a mobile or landline telephone

- Must be able to travel to group sessions, with or without transportation assistance

Exclusion Criteria

• Limited fluency in English posing significant barrier to deriving program benefit
We found this trial at
1
site
Ann Arbor, Michigan 48109
Phone: 844-862-5625
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials